Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer
by on Tuesday, January 24th, 2012 | No Comments
Condition: Gastric Cancer
Interventions: Drug: DOCETAXEL (XRP6976); Drug: OXALIPLATIN (SR96669); Drug: S-1 (1-(2-tetrahydrofuryl)-5-fluorouracil + CDHP (Gemeracil) + Oxo (Oteracil)
Sponsor: Sanofi-Aventis
Not yet recruiting – verified January 2012
Read more here: Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer